Sodium new houttuyfonate suppresses metastasis in NSCLC cells through the Linc00668/miR-147a/slug axis

Abstract

Background As most lung cancer patients present with invasive, metastatic disease, it is vital to investigate anti-metastatic treatments for non-small cell lung cancer (NSCLC). Houttuynia cordata is commonly used as a Chinese anticancer medicine in the clinic, and sodium new houttuyfonate (SNH), a main compound of this herb, has long been found to have antibiotic effects, although its anticancer effects have not been investigated. Here, we tried to address this lack of research from the perspective of the competing endogenous RNA (ceRNA) theory. Methods The effects of SNH on NSCLC cells were analysed with Cell Counting Kit-8 assays and colony formation assays. In addition, transwell assays and wound healing assays were used to determine the effects of SNH on migration and invasion in NSCLC cells. The levels of key genes and proteins were examined by quantitative real-time PCR, western blotting, immunofluorescence staining and IHC staining. Through transcriptome screening and digital gene expression profiling, Linc00668 was identified to be regulated by SNH. Dual-luciferase reporter assays and RNA immunoprecipitation assays verified the binding efficiency between miR-147a and Linc00668 or Slug. Results In the present study, SNH regulated NSCLC cells in multiple ways, the most prominent of which was suppressing the expression of Linc00668, which was indicated to promote migration and invasion in NSCLC cells. Functional studies demonstrated that Linc00668 acted as a ceRNA by sponging miR-147a to further regulate Slug mRNA levels, thereby influencing the progression of the epithelial-mesenchymal transition. Consistently, the results of in vivo animal models showed that SNH depressed Linc00668 and suppressed the metastasis of NSCLC. Conclusions SNH suppressed metastasis of NSCLC cells and the mechanism may involve with the Linc00668/miR-147a/Slug axis. Electronic supplementary material The online version of this article (10.1186/s13046-019-1152-9) contains supplementary material, which is available to authorized users.

Loss of lncRNA MIAT ameliorates proliferation and fibrosis of diabetic nephropathy through reducing E2F3 expression

“…In this theory, lncRNAs function via competing with shared microRNAs, which can play important roles in post‐transcriptional regulation 38 . It has demonstrated that miR‐147a is involved in some types of cancer 39,40 . Nevertheless, little is known about the role of miR‐147a in DN.…”

Linc00668 Promotes Invasion and Stem Cell-Like Properties of Breast Cancer Cells by Interaction With SND1

“…It has also been reported that Linc00668, associating with the PRC2 complex, epigenetically silenced the cyclin-dependent protein kinase inhibitors (CKIs) and promoted cell proliferation in gastric cancer (16). Linc00668 also functioned as a ceRNA to promote tumor progression in several types of cancer (17,(51)(52)(53)(54). In this study we observed that Linc00668 promoted breast cancer cell invasion, stem-cell like capacity, and Dox resistance via its binding to SND1.…”

miR-4293 Upregulates lncRNA WFDC21P by Directly Suppressing mRNA-Decapping Enzyme 2 to Promote Lung Carcinoma Proliferation

“…Accumulated studies have indicated that the prominent class of lncRNA share a common function in negatively impacting on miRNA-mediated gene regulation. [36,37] Interestingly, we found that, in contrast to ceRNA, not only WFDC21P could be up-regulated by miR-4293, but miR-4293 expression could be enhanced by WFDC21P through positive feedback. Both WFDC21P and miR-4293 play oncogenic roles in NSCLC.…”